Bayesian Capital Management, LP Heron Therapeutics, Inc. Transaction History

Bayesian Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.32 - $3.86 $110,431 - $183,736	47,600 New	47,600 $166,000
Q4 2023 Feb 14, 2024	BUY	$0.54 - $1.82 $10,962 - $36,946	20,300 New	20,300 $34,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $118,636 - $239,502	44,600 New	44,600 $188,000
Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $137,214 - $270,522	-12,600 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $128,898 - $309,456	12,600 New	12,600 $148,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $138M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.